For a patient diagnosed with chlamydia and trichomoniasis, what medications should be prescribed and what is the duration of therapy?

Treatment for Co-Infection with Chlamydia and Trichomoniasis

For a patient with both chlamydia and trichomoniasis, prescribe doxycycline 100 mg orally twice daily for 7 days PLUS metronidazole 500 mg orally twice daily for 7 days, and counsel the patient to abstain from sexual activity until both regimens are completed and all partners are treated. 1, 2

Chlamydia Treatment

First-Line Regimen

• Doxycycline 100 mg orally twice daily for 7 days is the preferred treatment, achieving approximately 98% microbiologic cure rate 1
• This regimen is superior to azithromycin in cost and is not associated with higher adverse event rates 1

Alternative Option (If Adherence Concerns)

• Azithromycin 1 g orally as a single dose provides approximately 97% cure rate and should be selected when:
  • Patient adherence to a 7-day course is doubtful 1
  • Follow-up is unpredictable 1
  • Directly observed therapy is required 1

Medication Dispensing

• Dispense medications on-site with the first dose taken under direct observation to maximize adherence 1

Trichomoniasis Treatment

Preferred Regimen

• Metronidazole 500 mg orally twice daily for 7 days is the first-line treatment 2
• The 7-day regimen is significantly more effective than single-dose therapy, with treatment failure rates of 11% versus 19% respectively (p<0.0001) 2
• This multi-day regimen should be the preferred treatment for trichomoniasis among women 2

Alternative (If Adherence Can Be Assured)

• Metronidazole 2 g orally as a single dose is an option, though less effective 3, 2
• Single-dose therapy has higher failure rates and should be reserved for situations where adherence to multi-day therapy is impossible 2

Treatment Failure Considerations

• If symptoms persist or recurrence occurs after initial metronidazole treatment, consider:
  • Metronidazole-resistant Trichomonas vaginalis 4
  • Reinfection from untreated partners 4
  • Treatment with tinidazole (oral and/or vaginal) for refractory cases 4

Critical Patient Counseling

Sexual Abstinence Requirements

• Abstain from all sexual activity for 7 days after completing BOTH treatment regimens 1
• Continue abstinence until all sexual partners have been treated to prevent reinfection 1

Partner Management

• All sexual partners must receive treatment for both infections to prevent reinfection and ongoing transmission 1
• Partners should be evaluated and treated promptly, as untreated partners are the main source of reinfection 5

Follow-Up Testing

Test-of-Cure (Not Routinely Needed)

• Routine test-of-cure at 3-4 weeks is not recommended for non-pregnant patients treated with recommended regimens 1
• Test-of-cure is indicated only when:
  • Treatment adherence is uncertain 1
  • Symptoms persist after therapy 1
  • Reinfection is suspected 1

Reinfection Screening (Strongly Recommended)

• Retest for chlamydia approximately 3 months after treatment regardless of partner treatment status 1
• Women should be retested again at their next medical visit within 3-12 months to detect reinfection, which raises the risk of pelvic inflammatory disease 1

Common Pitfalls to Avoid

• Do not test before 3 weeks post-treatment, as this may yield false-positive results from non-viable organisms or false-negative results from low-level persistent infection 1
• Do not use single-dose metronidazole as first-line for trichomoniasis given the significantly higher failure rate compared to 7-day therapy 2
• Do not assume partner treatment has occurred—reinfection rates are high even when partners report treatment 1
• Do not overlook concurrent sexually transmitted infections—screen for gonorrhea, syphilis, and HIV as clinically indicated 3, 6